faulty copper genes (almost always the result of consanguineous marriage) causes Wilson's disease. Heterozygotes are clinically well but may show some of the biochemical abnormalities.
Excess copper damages first the liver and then as copper is released from the dying hepatocytes it affects the brain, eyes, kidneys, bones and joints, and possibly the parathyroid glands.8 The definitive biochemical signs are, firstly, a low plasma concentration of caeruloplasmin, usually but not always below 200 mg 1, with low serum concentrations of copper (less than 12 6 mmol 1 (80 mtg 100 ml)).9 Secondly, the urinary copper excretion is high. (A high urinary output of copper is also, however, seen in biliary cirrhosis.10) Thirdly, the copper content of the liver is raised and histological examination of biopsy specimens shows fine fat droplets, nuclear vacuoles, and a positive stain for copper. Fourthly, there is an overall diminution of copper incorporation into caeruloplasmin and a prolonged turnover of body copper. And, finally, rusty brown Kayser-Fleischer rings near the limbus of the eye are said to occur in all cases with neurological damage."
Over The review was mainly concerned with three questions: whether the description of industrial bladder cancer was still satisfactory; what additional substances and occupations, if any, could be added to the terms of prescription; and whether there was evidence that carcinoma in situ could cause disablement before overt evidence of malignancy.
The council-whose members include doctors, lawyers, and representatives of industry, the trade uni,ns, and insurancerecommended that the description of the disease should be amended to include carcinoma in situ and invasive carcinoma: all forms of transitional cell carcinoma of the urothelium are now included. It added benzidine to paragraph (a)ii as many people did not understand the chemical description of benzidine and its related compounds. It clarified the problem regarding auramine and magenta: the handling of these substances is not thought to induce carcinogenesis but their actual manufacture may produce tumours.
Methylene-bis-orthochloroaniline has now been listed as a substance under paragraph (a)i. This recommendation has been derived mainly from studies on animals showing it to be carcinogenic, and in this respect Britain is falling into line with the United States. Research work on this substance will be kept under review. In Britain a few men have probably developed cancer of the bladder from exposure to methylenebis-orthochloroaniline.
Several other chemical compounds were considered by the council, but since the evidence was not convincing they were not included in the provisions. Nevertheless, research into (and evidence on) the effects of these substances is to be kept under review. Some evidence is accumulating that additional industries may have a raised incidence of neoplasm of the bladder-for example, printing. Concern has been expressed by the trade unions and the council has recommended a continuing review of epidemiological research into the occupational incidence of neoplasm of the bladder in specific occupations.
The last recommendation is that "every effort should be made to ensure that potential claimants, doctors, and trade unions are aware of the occupational causes of neoplasm of the bladder." At present too few claims are made owing to a lack of awareness by the potential claimants, trade unions, and doctors concerned. The advisory council has made efforts to publicise these changes by sending details to the Royal College of Surgeons, the British Association ofUrological Surgeons, the Royal Society of Medicine, the Royal College of General Practitioners, the Trades Union Council, and the Confederation of British Industry. The changes made in 1983 certainly go a long way to meeting my criticisms expressed in 1982.1 The disease can now be compensatable at an earlier stage-for example, for carcinoma in situ-and the changes should also allow a better understanding of the condition by people who write reports for either legal purposes or injury benefits. Unfortunately, the recommendations do not include any change in (a)ii, (a)iii, or (a)iv relating to the chemical description ofthe various chemicals (for the reasons stated in paragraph 9 of the report): the phrases nitro, primary amino, ring substitution by halogeno methyl or methoxy groups mean little to the average medical doctor or to me.
Official policy seems to be based on published reports on occupational or industrial cancer of the biadder, but this seems a very passive outlook. Surely in the future a more positive approach willbe 
Policies on prevention
Setting up committees rarely solves problems, and the proposal that every NHS district health authority should establish an "interdisciplinary heart disease team" seems an expensive way of promoting prevention of the disease. Coronary Heart Disease Prevention, the report of a conference held in September 1983, gives this suggestion priority, however, and suggests that around £12 million a year will be needed to finance prevention programmes in all the districts and NHS regions.' Surely this is an occasion when one or two regions might act as pilots to explore the possibilities rather than letting them all cut their teeth at the same time ?2
Nevertheless, the report does recommend the policies that are essential if Britain is to join the other countries with a declining frequency of coronary heart disease. Firstly-and in our view most important-politicians must be persuaded that a responsible government should have a policy on health and be prepared to take account of that policy in its decisions. The immediate issue is nutrition and its relation with agriculture. As the report explains, "the present operation of the European Economic Community Common Agricultural Policy in relation to dairy products and sugar is directly opposed to the food and health policy the United Kingdom should be aiming for." At a time when farm policies are being reviewed it is essential that the nutritional objectives set out last year by the National Advisory Committee on Nutrition Education should be incorporated into government thinking.3 Food regulations and carcase grading (the amount of fat on cattle and sheep, at present favouring fat animals) should also be revised with the same objectives as targets.
Secondly, a government committed to a health policy would also, we believe, be more aggressive in discouraging smoking and reducing consumption of alcohol. Thirdly, a government initiative is needed for health education to be given priority in all levels of education-but especially in the training of teachers.
The report suggests that primary health care teams "should accept their important responsibility" for prevention. Certainly medical commitment is patchy-perhaps because so many doctors have been taught to be sceptical of the value of screening and health check ups. Disenchantment with multichannel biochemical screening procedures should not, however, be used by doctors as an excuse for neglecting their obligation to seek out patients with symptomless hypertension or hyperlipidaemia-in whom treatment has been shown to be effective. Whether the proposals in the report for "motivating" the primary health care team will give similar clear cut gains seems less certain: changing peoples' attitudes to exercise and alcohol are not easy, nor are the optimum methods universally agreed.
No one would expect a report of this kind to satisfy all readers: preventive policies tend to provoke strong emotions because they necessarily impinge on individual freedoms and their paternalism upsets many people. The central concept of the report is, however, unchallengeable: as a nation we have delayed too long in formulating a strategy for preventing coronary heart disease. Both the medical profession and consumer bodies such as the College of Health should now maintain pressure on the government to recognise the need for urgent action.
